“immunomedics” Archives

in
Entry Author Date Location
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals 09/14/20 Seattle
Gilead Adds “Cornerstone” Cancer Drug in $21B Immunomedics Buyout 09/14/20 San Francisco
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More 04/24/20 National
Immunomedics Triple Negative Breast Cancer Drug Wins Early FDA Nod 04/22/20 New York
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce’s $88M & More 02/21/20 National
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More 05/03/19 National
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark 03/01/19 National
Bio Roundup: Aimmune Drama, Shutdown Blues, Perlmutter Talks Cancer 01/18/19 National
Bio Roundup: Big Apple Mo’, Checkpoint Yes and No, CAR-T Death & More 05/12/17 National
VenBio Settles Immunomedics Litigation, SeaGen Nixes Cancer Drug Deal 05/05/17 New York
Biotech Roundup: Obamacare Lite, DePinho Out, Dunsire In & More 03/10/17 National
VenBio-Backed Directors Wrest Control of Immunomedics Board 03/03/17 New York
Seattle Genetics Puts Up $250M for Immunomedics Cancer Drug Rights 02/10/17 Seattle
East Coast Life Sciences Roundup: Verdine, Ariad, Karyopharm, & More 10/11/13 Boston
Page 1 of 1